s6y
Company name or ticker
Search
LUNDEMOSE ANKER MD, PH.D, DSC
4
OSI PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities
Filed
Thursday, February 5, 2009
Period
Feb 3, 2009
Accession number
0001127602-09-002713
Documents
PRIMARY DOCUMENT
4
PRIMARY DOCUMENT
4
POWER OF ATTORNEY
EX-24
On sec.gov
Filing index
All files
Complete submission text
SGML header